Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM
US10912955B2 · kind B2 · utility
0Cited by
11References
11Claims
0Family size
Inventor
Key dates
| Filing date | Jul 8, 2016 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Jan 22, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG09G2380/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A process is provided for inhibiting symptoms of celiac disease, Clostridium difficile associated diseases such as Clostridium difficile colitis, pseudomembranous colitis and antibiotic associated diarrhea, food allergy or food intolerance in a subject that includes the oral administration to the subject suffering from food allergy or food intolerance an IgM. When administered in a, therapeutic quantity based on the subject characteristics and the type of IgM, symptoms of food allergy or food intolerance in that subject are inhibited. Even non-secretory forms of IgM are effective when administered orally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.